Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318731 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
A NA study, sponsored by University of Mary Hardin-Baylor.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03318731 is a NA study that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 60 participants.
The verdict
NCT03318731, a NA study, has completed, sponsored by University of Mary Hardin-Baylor.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized, repeated measures and double blind study which measures the effect of fenugreek extract on markers of muscle damage and inflammation in non-resistance trained males. Participants will complete baseline testing and then be randomized into groups. Participants will complete a 2 week, split-body resistance training program. They will then return for testing in which they will complete an overreaching protocol for 5 consecutive days. Measurements will be recorded 24 hrs after the fifth day. Participants will resume the training program for one additional week and return for final measurements.
Interventions
- OTHER Sugar Pill
- DIETARY_SUPPLEMENT Fenugreek Extract, Low Dose
- DIETARY_SUPPLEMENT Fenugreek Extract, High Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03318731
The ClinicalTrials.gov registry entry for NCT03318731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mary Hardin-Baylor, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sugar Pill is the first listed.
NCT03318731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03318731 about?
NCT03318731 is a clinical study titled "Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males". This is a randomized, repeated measures and double blind study which measures the effect of fenugreek extract on markers of muscle damage and inflammation in non-resistance trained males. Participants will complete baseline testing and then be randomized into groups. Participants will complete a 2 w...
What is the current status of trial NCT03318731?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-21. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT03318731?
The interventions under investigation include: Sugar Pill (OTHER), Fenugreek Extract, Low Dose (DIETARY_SUPPLEMENT), Fenugreek Extract, High Dose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03318731?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.